Healthia Gestion

Gestion contrôle des critères 3/4

Healthia's CEO is Wes Coote, appointed in Apr 2019, has a tenure of 4.58 years. total yearly compensation is A$660.60K, comprised of 60.2% salary and 39.8% bonuses, including company stock and options. directly owns 1.42% of the company’s shares, worth €2.16M. The average tenure of the management team and the board of directors is 1.3 years and 5.5 years respectively.

Informations clés

Wes Coote

Directeur général

AU$660.6k

Rémunération totale

Pourcentage du salaire du PDG	60.2%
Durée du mandat du directeur général	4.6yrs
Propriété du PDG	1.4%
Durée moyenne d'occupation des postes de direction	1.3yrs
Durée moyenne du mandat des membres du conseil d'administration	5.5yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Wes Coote a-t-elle évolué par rapport aux bénéfices de Healthia?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2023	AU$661k	AU$398k	AU$5m
Mar 31 2023	n/a	n/a	AU$3m
Dec 31 2022	n/a	n/a	AU$781k
Sep 30 2022	n/a	n/a	-AU$1m
Jun 30 2022	AU$516k	AU$345k	-AU$3m
Mar 31 2022	n/a	n/a	-AU$2m
Dec 31 2021	n/a	n/a	AU$161k
Sep 30 2021	n/a	n/a	AU$3m
Jun 30 2021	AU$400k	AU$306k	AU$5m
Mar 31 2021	n/a	n/a	AU$6m
Dec 31 2020	n/a	n/a	AU$7m
Sep 30 2020	n/a	n/a	AU$5m
Jun 30 2020	AU$313k	AU$225k	AU$3m
Mar 31 2020	n/a	n/a	AU$1m
Dec 31 2019	n/a	n/a	AU$271k
Sep 30 2019	n/a	n/a	-AU$483k
Jun 30 2019	AU$226k	AU$176k	-AU$1m

Rémunération vs marché: Wes's total compensation ($USD435.26K) is about average for companies of similar size in the German market ($USD603.52K).

Rémunération et revenus: Wes's compensation has been consistent with company performance over the past year.

PDG

Wes Coote

4.6yrs

Titularisation

AU$660,599

Compensation

Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Wesley Coote	Group MD	4.6yrs	AU$660.60k	1.42% € 2.2m
Damien Peters	Group Chief Financial Officer	less than a year	AU$319.83k	pas de données
Darren Stewart	Director of Podiatry & Executive Director	no data	AU$115.34k	6.4% € 9.7m
Lisa Roach	Group Chief Partnerships Officer & Executive Director	less than a year	AU$391.84k	0.75% € 1.1m
Colin Kangisser	CEO of Eyes & Ears Division and Director	2.6yrs	AU$368.92k	3.66% € 5.5m
Roy Walker	Chief Executive Officer of Bodies	less than a year	AU$314.24k	pas de données
Dean Hartley	Chief Technology Officer	1.8yrs	AU$261.49k	2.49% € 3.8m
Julia Murfitt	General Counsel & Company Secretary	1.8yrs	pas de données	pas de données
Anthony Ganter	Group Chief Business Development & Strategy Officer	no data	AU$341.32k	0% € 0
Kerrie Evans	Group Chief Education & Research Officer	no data	pas de données	pas de données
Aaron Kangisser	Chief Operating Officer of Eyes & Ears Division	less than a year	pas de données	pas de données

1.3yrs

Durée moyenne de l'emploi

Gestion expérimentée: HE3's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Wesley Coote	Group MD	4.6yrs	AU$660.60k	1.42% € 2.2m
Darren Stewart	Director of Podiatry & Executive Director	5.5yrs	AU$115.34k	6.4% € 9.7m
Lisa Roach	Group Chief Partnerships Officer & Executive Director	1.6yrs	AU$391.84k	0.75% € 1.1m
Colin Kangisser	CEO of Eyes & Ears Division and Director	2.6yrs	AU$368.92k	3.66% € 5.5m
Glen Richards	Non-Executive Chairman	5.5yrs	AU$130.00k	5.67% € 8.6m
Paul Wilson	Independent Non-Executive Director	5.5yrs	AU$80.00k	2.51% € 3.8m
Lisa Dalton	Independent Non-Executive Director	5.5yrs	AU$80.00k	0.034% € 51.3k

5.5yrs

Durée moyenne de l'emploi

Conseil d'administration expérimenté: HE3's board of directors are considered experienced (5.5 years average tenure).

Healthia Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

Healthia Limited Announces Board Changes

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought €54k worth of stock

Less than half of directors are independent

Healthia Limited, Annual General Meeting, Nov 23, 2022

Recent updates

Healthia Limited Announces Board Changes

Pacific Equity Partners made an offer to acquire Healthia Limited from MA Financial Group Limited (ASX:MAF), Wilson Asset Management (International) Pty Ltd. and Regal Partners Limited (ASX:RPL) for an offer per share of AUD 1.8.

New major risk - Financial position

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

Harold Bidco Pty Ltd made an offer to acquire Healthia Limited for an offer per share of AUD 1.8.

Full year 2023 earnings released: EPS: AU$0.046 (vs AU$0.028 loss in FY 2022)

Healthia Limited to Report Fiscal Year 2023 Results on Aug 31, 2023

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.03 (vs AU$0.001 loss in 1H 2022)

Healthia Limited (ASX:HLA) agreed to acquire Kosmac & Clemens Optometrists.

Healthia Limited Appoints Damien Peters as Group Chief Financial Officer

Healthia Announces Resignation of Chris Banks as CFO

Independent Non-Executive Director recently bought €54k worth of stock

Healthia Limited (ASX:HLA) completed the acquisition of Corio Bay Health Group.

Less than half of directors are independent

Healthia Limited (ASX:HLA) acquired Watsonia Physiotherapy.

Healthia Limited, Annual General Meeting, Nov 23, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Corio Bay Health Group.

Full year 2022 earnings released: AU$0.028 loss per share (vs AU$0.065 profit in FY 2021)

Healthia Limited Determines Not to Declare the Payment of A Final Dividend for 2022

Healthia Limited to Report Fiscal Year 2022 Results on Aug 31, 2022

Healthia Limited Provides Financial Guidance for the Year Ending June 30, 2022

Less than half of directors are independent

Healthia Limited Announces Board Changes

Now 20% undervalued

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Healthia Limited Announces Dividend on HLA - ORDINARY FULLY PAID for the Six Months Ended 31 Dec. 2021, Payable on 24 March 2022

Healthia Limited Recommends Interim Dividend, Payable on March 22, 2022

Healthia Limited to Report First Half, 2022 Results on Feb 28, 2022

Healthia Limited (ASX:HLA) entered into binding agreement to acquire Mornington Peninsula Family Physiotherapy.

Less than half of directors are independent

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Membres du conseil d'administration

Durée moyenne de l'emploi